+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia



Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia



Indian Journal of Gastroenterology 23(4): 131-134



Aim: To evaluate the efficacy and safety of three hypolipidaemic agents in patients with non-alcoholic fatty liver disease associated with hyperlipidaemia. Methods: Patients from Greece with dyslipidaemia (Fredrickson type IIb), asymptomatic persistent transaminasemia lasting 24 weeks, and evidence of hepatic fat infiltration on ultrasonography and liver biopsy were studied.

(PDF emailed within 1 workday: $29.90)

Accession: 004140252

Download citation: RISBibTeXText

PMID: 15333967


Related references

Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action. Molecular Aspects of Medicine: -, 2018

Fatty acid omega- and (omega-1)-hydroxylation in experimental alcoholic liver disease: relationship to different dietary fatty acids. Alcoholism, Clinical and Experimental Research 22(7): 1493-1500, 1998

Omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics: 7, 679-692, 2010

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World Journal of Gastroenterology 18(41): 5839-5847, 2013

Omega-3 polyunsaturated fatty acids: a specific liver drug for non-alcoholic fatty liver disease (NAFLD). Medical Hypotheses 71(5): 820-821, 2008

Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 31(7): 679-692, 2010

PWE-100 A clinical trial investigating the effect of omega-3 fatty acids on non-alcoholic fatty liver disease. Gut 64(Suppl 1): A256.1-A256, 2015

Fatty acid omega- and -hydroxylation in experimental alcoholic liver disease Relationship to different dietary fatty acids. Alcoholism Clinical & Experimental Research 22(7): 1493-1500, 1998

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. Bmc Pediatrics 13: 85-85, 2013

Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. Journal of Nutritional Biochemistry 58: 28-36, 2018

The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs. Pakistan Journal of Medical Sciences 33(4): 1022-1028, 2017

Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. Plos One 11(10): E0162368-E0162368, 2016

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease. Journal of Diabetes and Its Complications 28(5): 711-714, 2015

Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition 37(2): 516-521, 2017

Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomedical Reports 9(1): 90-96, 2018